Risk relationship between dyslipemia and COVID-19

The presence of dyslipemia in patients with COVID-19 seems to increase the clinical course of the disease. In this literature review the main mechanisms that link them and their implications in the treatment of the affected patients are described. To carry out this work a literature search was made...

Full description

Bibliographic Details
Main Authors: Izaida Lis Montero López, Wardy Castillo López, Silvio Niño Escofet, Pedro Enrique Miguel Soca
Format: Article
Language:Spanish
Published: Centro Provincial de Información de Ciencias Médicas 2022-09-01
Series:Medisan
Subjects:
Online Access:http://medisan.sld.cu/index.php/san/article/view/3999
_version_ 1818065133527629824
author Izaida Lis Montero López
Wardy Castillo López
Silvio Niño Escofet
Pedro Enrique Miguel Soca
author_facet Izaida Lis Montero López
Wardy Castillo López
Silvio Niño Escofet
Pedro Enrique Miguel Soca
author_sort Izaida Lis Montero López
collection DOAJ
description The presence of dyslipemia in patients with COVID-19 seems to increase the clinical course of the disease. In this literature review the main mechanisms that link them and their implications in the treatment of the affected patients are described. To carry out this work a literature search was made in databases, such as academic Google, SciELO, Annual Reviews and PMC. The analyzed describers were COVID-19, SARS-CoV-2, dyslipemia, LDL-cholesterol, HDL-cholesterol, triglycerides, hypercholesterolemia and VLDL lipoproteins. Articles of magazines arbitrated by pairs and available to complete text, published in English and Spanish were preferably revised.  In spite of the controversies, dyslipemia is a risk factor of unfavorable prognosis in patients affected with COVID-19 and the treatment for the patients with that unfavourable condition improve this prognosis.
first_indexed 2024-12-10T14:47:03Z
format Article
id doaj.art-71c24d0c52f94a73a6069689b86237fc
institution Directory Open Access Journal
issn 1029-3019
language Spanish
last_indexed 2024-12-10T14:47:03Z
publishDate 2022-09-01
publisher Centro Provincial de Información de Ciencias Médicas
record_format Article
series Medisan
spelling doaj.art-71c24d0c52f94a73a6069689b86237fc2022-12-22T01:44:33ZspaCentro Provincial de Información de Ciencias MédicasMedisan1029-30192022-09-01264e3999e39991192Risk relationship between dyslipemia and COVID-19Izaida Lis Montero López0Wardy Castillo López1Silvio Niño Escofet2Pedro Enrique Miguel Soca3Escuela Superior Politécnica de Chimborazo. Riobamba, ChimborazoEscuela Superior Politécnica de Chimborazo. Riobamba, ChimborazoUniversidad de Ciencias Médicas de Holguín. HolguínUniversidad de Ciencias Médicas de Holguín. HolguínThe presence of dyslipemia in patients with COVID-19 seems to increase the clinical course of the disease. In this literature review the main mechanisms that link them and their implications in the treatment of the affected patients are described. To carry out this work a literature search was made in databases, such as academic Google, SciELO, Annual Reviews and PMC. The analyzed describers were COVID-19, SARS-CoV-2, dyslipemia, LDL-cholesterol, HDL-cholesterol, triglycerides, hypercholesterolemia and VLDL lipoproteins. Articles of magazines arbitrated by pairs and available to complete text, published in English and Spanish were preferably revised.  In spite of the controversies, dyslipemia is a risk factor of unfavorable prognosis in patients affected with COVID-19 and the treatment for the patients with that unfavourable condition improve this prognosis.http://medisan.sld.cu/index.php/san/article/view/3999covid-19sars-cov-2dislipidemialdl-colesterolhdl-colesterol triglicéridoshipercolesterolemialipoproteínas vldl.
spellingShingle Izaida Lis Montero López
Wardy Castillo López
Silvio Niño Escofet
Pedro Enrique Miguel Soca
Risk relationship between dyslipemia and COVID-19
Medisan
covid-19
sars-cov-2
dislipidemia
ldl-colesterol
hdl-colesterol triglicéridos
hipercolesterolemia
lipoproteínas vldl.
title Risk relationship between dyslipemia and COVID-19
title_full Risk relationship between dyslipemia and COVID-19
title_fullStr Risk relationship between dyslipemia and COVID-19
title_full_unstemmed Risk relationship between dyslipemia and COVID-19
title_short Risk relationship between dyslipemia and COVID-19
title_sort risk relationship between dyslipemia and covid 19
topic covid-19
sars-cov-2
dislipidemia
ldl-colesterol
hdl-colesterol triglicéridos
hipercolesterolemia
lipoproteínas vldl.
url http://medisan.sld.cu/index.php/san/article/view/3999
work_keys_str_mv AT izaidalismonterolopez riskrelationshipbetweendyslipemiaandcovid19
AT wardycastillolopez riskrelationshipbetweendyslipemiaandcovid19
AT silvioninoescofet riskrelationshipbetweendyslipemiaandcovid19
AT pedroenriquemiguelsoca riskrelationshipbetweendyslipemiaandcovid19